Ibovespa rises 6% in March, first monthly increase in 2021, with radar vaccination By Reuters

Ibovespa rises 6% in March, first monthly increase in 2021, with radar vaccination By Reuters
Ibovespa rises 6% in March, first monthly increase in 2021, with radar vaccination By Reuters

© Reuters. .

Por Paula Arend Laier

SAO PAULO (Reuters) – The accumulated in March high of 6%, the first positive monthly performance of the year, with companies that tend to benefit from the reopening of the economy, such as shopping centers, among the biggest gains, despite the country experiencing the worst moment of the Covid-19 pandemic.

Amid daily records of deaths, Brazil has accounted 317,646 deaths from coronavirus in the country since the beginning of the pandemic, with 12,658,109 confirmed cases, according to data from Tuesday from the Ministry of Health. It is the second country in the world with the most cases and deaths by Covid, behind only the USA.

But among financial agents there is a growing perception that the pace of vaccination tends to gain traction, with new contracts signed between the Brazilian government and laboratories, in addition to a slightly more pro-vaccine tone from authorities in Brasília.

In the first statements after taking over the Ministry of Health, Marcelo Queiroga promised to more than triple the rate of vaccination soon, to more than 1 million doses per day.

According to data from the ministry, 14,322,996 people have already received the first dose of the vaccine, while 4,150,441 have already taken the second dose. The population able to receive the vaccine is 170 million people in Brazil.

In the view of the allocation leader at BlueTrade, Marina Braga, confidence in the vaccine is no longer a concern, since it has already been developed, and there is already an evolution in countries with faster immunization rates, such as Israel and the United States.

“In Brazil, it is a matter of time for this to happen,” he said.

Anvisa approved this Wednesday emergency use in Brazil of the vaccine from Janssen, a subsidiary of Johnson & Johnson (NYSE

Get the latest news delivered to your inbox

Follow us on social media networks

PREV See what are the 3 main reasons for credit card refusal
NEXT woman who tried to resume dating by PIX is highlighted